TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
882,853
|
802,540
|
366,778 |
Financial expenses |
656
|
19,484
|
22,947 |
Earnings before taxes |
268,264
|
208,173
|
65,804 |
EBITDA |
244,765
|
182,191
|
77,721 |
Total assets |
4,702,673
|
4,649,563
|
3,978,133 |
Current assets |
991,192
|
826,371
|
616,909 |
Current liabilities |
234,937
|
305,908
|
232,377 |
Equity capital |
4,345,212
|
4,236,451
|
3,585,074 |
- share capital |
2,551
|
2,540
![]() |
2,540 |
Employees (average) |
249
|
227
|
121 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
92.4%
|
91.1%
|
90.1% |
Turnover per employee |
3,546
|
3,535
|
3,031 |
Profit as a percentage of turnover |
30.4%
|
25.9%
|
17.9% |
Return on assets (ROA) |
5.7%
|
4.9%
|
2.2% |
Current ratio |
421.9%
|
270.1%
|
265.5% |
Return on equity (ROE) |
6.2%
|
4.9%
|
1.8% |
Change turnover |
80,313
|
435,762
|
261,979 |
Change turnover % |
10%
|
119%
|
250% |
Chg. No. of employees |
22
|
106
|
64 |
Chg. No. of employees % |
10%
|
88%
|
112% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.